Summary
A simple method is described for the separate determination in plasma of lipophilic drugs and their more hydrophilic metabolites by liquid scintillation counting. This is done by measuring the radioactivity after adding biological specimens to a scintillation liquid which takes up both the unchanged drug and its hydrophilic metabolites (Bray's solution), and by mixing further aliquots of the specimen with a scintillation fluid which only takes up unchanged drug (Toluene+PPO=TSC). The amount of hydrophilic substances dissolved in TSC, as well as irradiation from the aqueous phase, were shown to be less than 13% for both of the isotopes3H and14C, employing 0.5 ml of aqueous phase added to 10 ml toluene scintillant. Checking the method by thin layer chromatography showed that the concentrations of fentanyl and haloperidol in plasma were determined accurately. After taking account of a special procedure used to dissolve a greater proportion of morphine in toluene, the ratio of TSC and BSC measurements was in agreement with data obtained by thin layer chromatography. Experiments with chlorpromazine showed that lipophilic degradation products were formed which could not be separated from the original drug by liquid-liquid partition. In such cases, therefore, the method cannot be employed. Etorphine is an example of how reliable results were obtained despite low dosage and relatively low specific activity of this drug.
Similar content being viewed by others
References
Berkowitz, B.A., Asling, J.H., Shnider S.M., Way, E.L.: Relationship of pentacocine plasma levels to pharmacological activity in man. Clin. pharmacol. Ther.10, 320–327 (1969).
Bray, G.A.: A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter. Analyt. Biochem.1 279–285 (1960).
Dobbs, H.E., Hall, J.M.: Metabolism and biliary excretion of etorphine (M99-Reckitt) — an extremely potent morphine-like drug. Proc. Europ. Soc. Study Drug Toxic.10, 77–86 (1969).
Dost, F.H.: Grundlagen der Pharmakokinetik. Stuttgart: G. Thieme Verlag 1968.
Efron, D.H.: Levels of psychotropic drugs in plasma and their action in man. In: Pharmacological and Clinical Significance of Pharmacokinetics. Stuttgart-New York: Schattauer Verlag 1969.
Hayes, A., Cooper, R.G.: Studies on the absorption, distribution and excretion of propanolol in rat, dog and monkey. J. Pharmacol. exp. Ther.176, 302–311 (1971).
Hess, R., Herz, A., Friedel, K.: Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect. J. Pharmacol. exp. Ther.179, 474–484 (1971).
Hess, R., Stiebler, G., Herz, A.: Pharmacokinetics of fentanyl in man and rabbits. Europ. J. clin. Pharmacol.4, 137–141 (1972).
Hollister, L.E., Clyde, D.J.: Blood levels of pentobarbital sodium meprobamate and tybamate in relation to clinical effects. Clin. Pharmacol. Ther.9, 204–208 (1968).
Houtman, A.C.: Liquid scintillation counting of blood. Int. J. Appl. Radiat. Isotop.16, 65–70 (1965).
Krüger-Thiemer, E.: Application of kinetic analyses for calculation of dosage regimens. In: Pharmacologic Techniques in Drug Evaluation Vol. 2, Siegler and Moyer (Eds.). Chicago: Year Book Med. Publishers Inc. 1967.
Maickel, R.P.: The use of labelled drugs in psychopharmacology research. In: Advances in Tracer Methodology, Vol. 4, 177–186. New York: Rothschield (Ed), Plenum Press 1968.
Parmentier, J.H., L ten Haaf, F.E.: Developments in liquid scintillation counting since 1963. Int. J. Appl. Radiat. Isotop.20, 305–334 (1969).
Sheperd, M., Lader, M., Rodnight, R.: Clinical Psychopharmacology. English University Press p. 13, (1968).
Way, E.L., Adler, T.K.: The biological disposition of morphine and its surrogates. Bull. Wld Hlth Org.25, 227–262 (1961).
Whyman, A.E.: Measurement of tritium in neat plasma and urine with a toluene/triton X-100/Hyamine 10-X Scintillant. Int. J. Appl. Radiat. Isotop.21, 81–86 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, R., Leschem, D., Teschemacher, H. et al. A simple method for the separate estimation of labelled drugs and their metabolites by liquid scintillation counting. Some practical examples. Eur J Clin Pharmacol 5, 104–110 (1972). https://doi.org/10.1007/BF00561754
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561754